These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 24584911)
1. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents. Cheson BD; Heitner Enschede S; Cerri E; Desai M; Potluri J; Lamanna N; Tam C Oncologist; 2017 Nov; 22(11):1283-1291. PubMed ID: 28851760 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Blum KA; Ruppert AS; Woyach JA; Jones JA; Andritsos L; Flynn JM; Rovin B; Villalona-Calero M; Ji J; Phelps M; Johnson AJ; Grever MR; Byrd JC Leukemia; 2011 Sep; 25(9):1444-51. PubMed ID: 21606960 [TBL] [Abstract][Full Text] [Related]
3. Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Wang WD; Gale RP; Liang Y N Engl J Med; 2024 May; 390(17):1633-1634. PubMed ID: 38692303 [No Abstract] [Full Text] [Related]
4. Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Kurosawa S; Yokota T; Takada Y; Okubo S; Masuda M; Nakayama H; Sakurai A; Ito C; Aisa Y; Nakazato T Ann Hematol; 2024 May; 103(5):1779-1781. PubMed ID: 38512464 [No Abstract] [Full Text] [Related]
5. Recurrent Malignant Melanoma Presenting as Isolated Pleural Metastases in a Patient with Chronic Lymphocytic Leukemia. Anand K; Cingam S; Peddi P Case Rep Oncol; 2017; 10(1):86-90. PubMed ID: 28203169 [TBL] [Abstract][Full Text] [Related]
6. Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia. Soyaltin UE; Yuce Yildirim D; Yildirim M; Ugur MC; Ekinci F; Ceylan C; Akar H Case Rep Hematol; 2016; 2016():7362791. PubMed ID: 27885347 [TBL] [Abstract][Full Text] [Related]
7. Bullous leukemia cutis mimicking facial cellulitis. Caldato Lde S; Britto Jde S; Niero-Melo L; Miot HA An Bras Dermatol; 2016 Apr; 91(2):248-9. PubMed ID: 27192532 [TBL] [Abstract][Full Text] [Related]
8. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report. Annaloro C; Costa A; Fracchiolla NS; Mometto G; Artuso S; Saporiti G; Tagliaferri E; Grifoni F; Onida F; Cortelezzi A Clin Case Rep; 2015 Jul; 3(7):650-5. PubMed ID: 26273463 [TBL] [Abstract][Full Text] [Related]
9. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy]. Tsuji T; Hirano T; Yamasaki H; Tuda H Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia. Garrote H; de la Fuente A; Oña R; Rodríguez I; Echevarría JE; Sepúlveda JM; García JF Exp Hematol Oncol; 2015; 4():8. PubMed ID: 25767742 [TBL] [Abstract][Full Text] [Related]
11. Extensive acute toxic leukoencephalopathy induced by fludarabine: two months follow-up on brain MRI. Crombe A; Alberti N; Gilles M; Guy A; De Roquefeuil E; Dousset V; Tourdias T J Neuroradiol; 2015 Apr; 42(2):127-30. PubMed ID: 25454396 [No Abstract] [Full Text] [Related]
12. Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen. Dominguez N; Manzano ML; Muñoz R; Martin A; Fernandez I; Castellano G Leuk Lymphoma; 2015 Apr; 56(4):1160-3. PubMed ID: 25115508 [No Abstract] [Full Text] [Related]